High-Alert Medications

Related Procedures

Medications with heightened harm risk (ISMP): anticoagulants, insulins, opioids, neuromuscular blockers, concentrated electrolytes. High-alert safety strategies and ISMP tall man lettering tested on PTCB exam.

Related drug class: Statins includes atorvastatin, rosuvastatin, simvastatin. Mechanism: HMG-CoA reductase inhibitors, decrease hepatic cholesterol synthesis, upregulate LDL receptors.

Equipment & Tools

Medications with heightened harm risk (ISMP): anticoagulants, insulins, opioids, neuromuscular blockers, concentrated electrolytes. High-alert safety strategies and ISMP tall man lettering tested on PTCB exam.

Related drug class: ACE inhibitors includes lisinopril, enalapril, ramipril. Mechanism: Block angiotensin-converting enzyme, decrease angiotensin II, cause vasodilation and decreased aldosterone.

Patient Communication

Clear communication about high-alert medications with patients, families, and the healthcare team is essential. Use standardized handoff tools (SBAR) for shift changes and transfers. Verify understanding by asking the patient to repeat key information back to you.

Regulatory Context

Regulatory framework for high-alert medications in pharmacy:

Schedule II

High abuse potential with accepted medical use. Examples: oxycodone, fentanyl, morphine, amphetamine, methylphenidate. Storage: Double-locked, perpetual inventory, no refills, written/electronic Rx only

Schedule V

Lowest abuse potential. Examples: pregabalin, some cough syrups with codeine. Storage: May be OTC in some states with logbook

Troubleshooting

When high-alert medications does not go as expected, systematically review each step of the procedure. Check equipment calibration, verify technique, and repeat the measurement if results seem inconsistent with the clinical picture. Report discrepancies to the supervisor rather than guessing at the correct value.